UNSW researchers have secured funding for 38 projects in the latest National Health and Medical Research Council funding round.
Almost three quarters of child cancer survivors increased their general exercise after just one consultation with an exercise physiologist, a UNSW Sydney study has found. The sessions were also motivational, with 9 out of 10 kids reporting they wanted to increase their fitness levels.
Researchers have shown why people with intellectual disability experience lower life expectancy and suggest better public health could improve outcomes.
Pancreatic cancer is an insidious disease – it is often diagnosed at an advanced stage, with about 90% of patients dying within five years of diagnosis. New projections suggest pancreatic cancer will be the second leading cause of cancer mortality by 2025.
At a recent Therapeutic Development Workshop, experts shared perspectives on the challenges of moving a therapy from basic research discovery to the clinic - exploring all stages of therapeutic development
UNSW researchers have won half of the awards announced at the NSW Premier’s Prizes for Science & Engineering on Tuesday night at Government House in Sydney, including the top prize for NSW Scientist of the Year.
“Your child has cancer.” Being confronted with a child’s serious illness – particularly a disease as devastating as cancer – is any parent’s worst nightmare, and going through diagnosis, treatment, recovery and sometimes bereavement is heartbreaking.
UNSW Conjoint Associate Professor Tracey O’Brien, Director of the Kids Cancer Centre at Sydney Children’s Hospital at Randwick, was named winner in the category of Innovation at the Australian Financial Review’s 100 Women of Influence Awards o
Eight UNSW Sydney and UNSW-affiliated researchers have been elected Fellows of the Australian Academy of Health and Medical Sciences (AAHMS).
The researchers were among 40 new Fellows, including 19 women, announced today at the Academy’s fifth annual meeting in Perth.
UNSW medical researchers have shown how a biomarker could help doctors more accurately diagnose one of the rarest types of ovarian cancer.